Business Context and Reporting Period
Company: Emmis Acquisition Corp. (EMIS)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025 (Inception: March 21, 2025)
Business Model: A Cayman Islands exempted company (Special Purpose Acquisition Company or "SPAC") formed to effect a merger, share exchange, or asset acquisition with one or more businesses. The Company has no operating history and has generated no operating revenues to date. It intends to focus on industrial, business services, manufacturing, transportation, distribution, and technology sectors in North America and Southeast Asia.
Key Financial Metrics
| Metric | Value |
|---|---|
| Net Income | $840,557 |
| Operating Costs | $309,049 |
| Interest Income (Trust Account) | $1,149,606 |
| Cash and Cash Equivalents (Outside Trust) | $947,868 |
| Trust Account Balance | $116,149,606 |
| Total Assets | $117,320,852 |
| Total Liabilities | $96,707 |
| Shares Outstanding (Class A Public) | 11,500,000 |
| Shares Outstanding (Class B Founder) | 3,833,333 |
Material Changes and IPO Details
The Company consummated its Initial Public Offering (IPO) on September 26, 2025. This represents the primary material event for the reporting period.
- IPO Proceeds: Sold 11,500,000 Units (including full exercise of 1,500,000 over-allotment units) at $10.00 per unit, generating gross proceeds of $115,000,000.
- Private Placement: Simultaneously sold 367,500 Private Placement Units to the Sponsor and I-Bankers Securities, Inc. at $10.00 per unit, generating $3,675,000.
- Trust Account: $115,000,000 was deposited into a U.S.-based trust account. As of December 31, 2025, the balance grew to $116,149,606 due to interest income.
- Transaction Costs: Total costs were $2,316,412, comprising a $1,725,000 underwriting fee and $591,412 in other offering costs.
- Working Capital: Approximately $947,868 in cash is held outside the trust account for working capital and transaction expenses.
Guidance, Outlook, and Risks
Outlook and Timeline: The Company has 18 months from the closing of the IPO (until approximately March 2027) to consummate an initial business combination. If no combination is completed, the Company will liquidate and redeem public shares at a pro rata share of the trust account (initially $10.00 per share, plus interest).
Management Commentary: Management intends to leverage its experience in capital markets and M&A to identify targets with demonstrable revenues and EBITDA. The Company is an "emerging growth company" and a "smaller reporting company," allowing for reduced disclosure obligations.
Key Risks and Contingencies:
- Completion Risk: No target has been selected; failure to complete a combination within 18 months results in liquidation.
- Dilution: Founder shares were purchased for approximately $0.007 per share, creating significant potential dilution for public shareholders upon conversion.
- Redemption Risk: Public shareholders may redeem shares upon a business combination, potentially reducing cash available for the transaction.
- Regulatory Risk: Potential CFIUS review due to non-U.S. directors; potential classification as an investment company under the Investment Company Act.
- Market Risk: Geopolitical tensions (Middle East, Russia-Ukraine) and inflation could impact target availability and valuation.
Investor Verification Checklist
- Trust Account Status: Verify the current balance and interest rate of the trust account to confirm the redemption value per share.
- Extension Provisions: Review the Amended and Restated Memorandum and Articles of Association for terms regarding extending the 18-month combination period and associated redemption rights.
- Sponsor Commitments: Confirm the Sponsor's indemnification obligations regarding third-party claims against the trust account and the status of the $10,000 monthly administrative fee.
- Founder Share Lock-up: Verify the lock-up period for founder shares (typically one year post-combination or until share price exceeds $12.00).
- Related Party Transactions: Monitor for any loans from the Sponsor or affiliates used to fund working capital, which may be convertible into post-combination equity.